A Phase Ii, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study To Evaluate The Efficacy, Safety, And Pharmacokinetics Of Obinutuzumab When Given In Combination With Mycophenolate Mofetil And Corticosteroids In Adolescent Participants With Active Class Iii Or Iv Lupus Nephritis